-CNBC’s ‘Fast Money: Halftime Report’
Vertex Pharma’s Stem Cell Derived Diabetes Treatment Trial Put On Hold
The FDA has instituted a clinical hold on Vertex Pharmaceuticals Incorporated’s (NASDAQ:VRTX) VX-880 Phase 1/2 study due to a determination that there…